Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply
- PMID: 36322861
- DOI: 10.1056/NEJMc2211969
Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply
Comment on
-
Teclistamab in Relapsed or Refractory Multiple Myeloma.N Engl J Med. 2022 Nov 3;387(18):1721. doi: 10.1056/NEJMc2211969. N Engl J Med. 2022. PMID: 36322859 No abstract available.
-
Teclistamab in Relapsed or Refractory Multiple Myeloma.N Engl J Med. 2022 Nov 3;387(18):1721-1722. doi: 10.1056/NEJMc2211969. N Engl J Med. 2022. PMID: 36322860 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical